Ribosomal protein S26 pseudogene 49 (RPS26P49)

Ribosomal protein S26 pseudogene 49 (RPS26P49) is a processed pseudogene derived from the functional ribosomal protein S26 (RPS26) gene. Processed pseudogenes are DNA sequences resembling functional genes but are typically non-functional due to mutations, truncations, or lack of regulatory elements. RPS26P49 does not produce a functional protein and is not known to have any direct biological function, disease association, or drug interactions in humans. Ribosomal pseudogenes are numerous in the human genome; they arise from retrotransposition events and serve as genetic markers or evolutionary remnants rather than as therapeutic targets[5][10]. Key Points: - RPS26P49 is a **pseudogene**, not a functional protein-coding gene, receptor, enzyme, or other druggable target[10][5]. - There is **no evidence** that RPS26P49 has any known biological function, disease linkage, or relevance in pharmacology or biomarker studies. - The **functional gene** RPS26 (ribosomal protein S26) is involved in ribosomal structure and protein synthesis, and its mutations can cause Diamond-Blackfan anemia[7][11]. However, RPS26P49 does not contribute to ribosome activity. - The inclusion of RPS26P49 as a target is incorrect for drug development, therapeutic intervention, or biomarker use. Summary: Ribosomal protein S26 pseudogene 49 (RPS26P49) is a non-coding genomic pseudogene and not considered a true molecular target for therapeutic or research purposes[10][5].

Other names

RPS26_27_1414RPS26P49